TP53 and neoplasm: This is in accord with our results showing that both the tumor-suppressor TP53 gene -- a normally biallelically expressed gene located at band p13.1 of chromosome 17 -- and the non-coding pericentromeric region of chromosome 17 (CEN17) display epigenetic alterations in the patients' cells.